BURNABY, BRITISH COLUMBIA--(Marketwired - April 24, 2014) - LED Medical Diagnostics Inc. ("LED Medical" or the "Company") (TSX VENTURE:LMD)(OTCQX:LEDIF)(FRANKFURT:LME) is pleased to report that the LED Imaging Division of its wholly-owned US operating subsidiary, LED Dental Ltd. ("LED Dental") will be heading to the American Association of Orthodontists (AAO) Annual Session in New Orleans with two big announcements rolling out at the show. First, Tom Kearney, an industry leader with more than 30 years of experience, has joined the LED Imaging team and will assist with future endeavors in the orthodontic market. Additionally, LED Imaging is launching its LED Imaging Software to integrate with the company's growing portfolio of imaging technologies.
In his new role, Kearney will help establish strong relationships with practice consultants to further build out LED Imaging's customer base. He will also work to maximize corporate sponsorships, partnerships and other industry relationships. Prior to joining LED Imaging, Kearney most recently served as the director of corporate events for Carestream Dental, applying his decades of corporate events and tradeshow experience to cultivating strong relationships with customers. Kearney, an original founder of OrthoTrac software, helped establish the product as a premier orthodontic practice management software around the world in markets such as the U.S., the United Kingdom and Australia. His experience will serve him well as he supports LED Imaging in launching digital imaging and software products.
"I've had the pleasure of working with Tom for many years during my tenure at Carestream Dental, and I'm very excited for the opportunity to work with him again," said Lamar Roberts, president of LED Dental. "We have no doubt that Tom is the perfect addition to our team and will have an immediate impact as LED Imaging expands into the orthodontic market."
First up on Kearney's agenda is assisting with the recent launch of LED Imaging's premier digital extraoral imaging system, the RAYSCAN α - Expert, which offers CBCT, panoramic and cephalometric capabilities. Developed by Ray Co., Ltd., a subsidiary of Samsung Electronics, the system's high-quality imaging and optimal 9 cm x 9 cm field of view is ideal for orthodontists.
Kearney will also help introduce LED Imaging's exclusive imaging software at the AAO Annual Session. LED Imaging Software captures and displays intraoral and extraoral 2D radiographs, videos and photographs from a variety of diagnostic imaging devices. It also integrates seamlessly with the RAYSCAN α - Expert. LED Imaging Software is designed with true open-architecture, allowing integration with any practice management system and compatibility with imaging devices from a variety of manufacturers. The imaging software enables practitioners to capture, manipulate, save, store and share clinical images quickly and easily.
"Our number one goal is to provide the dental industry with top-of-the-line imaging and software products, so we're excited about all of the announcements we've made recently," Roberts continued. "We've accomplished so much already in 2014, and it's just the beginning - we have a very bright future ahead."
AAO Annual Session attendees are encouraged to visit LED Imaging's booth number 754, to meet Tom Kearney and demo the RAYSCAN α - Expert and LED Imaging Software. To learn more about LED Imaging, visit www.led-imaging.com.
About LED Dental Ltd.
LED Dental is a wholly owned subsidiary of LED Medical Diagnostics Inc. Founded by the creator of the award-winning VELscope® tissue fluorescence visualization technology, LED Dental now also features the LED Imaging division that provides dentists and oral health specialists with advanced diagnostic imaging products and software. Backed by an experienced leadership team dedicated to a higher level of service and support, LED Dental products seamlessly integrate into dental practices. The company is committed to providing dental practitioners with the best technology available by identifying and adding strong products to its growing portfolio. For more information, call 888.541.4614 or visit www.leddental.com.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED‐based visualization technologies for the medical industry. The company designs and manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. Available through major dental supply distributors, the VELscope® Vx is used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. LED Medical Diagnostics is currently listed on the Toronto Stock Exchange (TSX‐V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit www.ledmd.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy for the United States, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2013. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.